413 related articles for article (PubMed ID: 17392042)
1. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers.
Chouzouri G; Xanthos M
Acta Biomater; 2007 Sep; 3(5):745-56. PubMed ID: 17392042
[TBL] [Abstract][Full Text] [Related]
2. Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass.
Li H; Du R; Chang J
J Biomater Appl; 2005 Oct; 20(2):137-55. PubMed ID: 16183674
[TBL] [Abstract][Full Text] [Related]
3. Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies.
Ni S; Lin K; Chang J; Chou L
J Biomed Mater Res A; 2008 Apr; 85(1):72-82. PubMed ID: 17688291
[TBL] [Abstract][Full Text] [Related]
4. An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma.
Rai B; Teoh SH; Ho KH
J Control Release; 2005 Oct; 107(2):330-42. PubMed ID: 16085332
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites.
Misra SK; Mohn D; Brunner TJ; Stark WJ; Philip SE; Roy I; Salih V; Knowles JC; Boccaccini AR
Biomaterials; 2008 Apr; 29(12):1750-61. PubMed ID: 18255139
[TBL] [Abstract][Full Text] [Related]
6. Modulation of polycaprolactone composite properties through incorporation of mixed phosphate glass formulations.
Shah Mohammadi M; Ahmed I; Marelli B; Rudd C; Bureau MN; Nazhat SN
Acta Biomater; 2010 Aug; 6(8):3157-68. PubMed ID: 20206722
[TBL] [Abstract][Full Text] [Related]
7. Gel-derived bioglass as a compound of hydroxyapatite composites.
Cholewa-Kowalska K; Kokoszka J; Laczka M; Niedźwiedzki L; Madej W; Osyczka AM
Biomed Mater; 2009 Oct; 4(5):055007. PubMed ID: 19779249
[TBL] [Abstract][Full Text] [Related]
8. In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics.
Ni S; Chang J
J Biomater Appl; 2009 Aug; 24(2):139-58. PubMed ID: 18801892
[TBL] [Abstract][Full Text] [Related]
9. Bioactive composites consisting of PEEK and calcium silicate powders.
Kim IY; Sugino A; Kikuta K; Ohtsuki C; Cho SB
J Biomater Appl; 2009 Aug; 24(2):105-18. PubMed ID: 18757493
[TBL] [Abstract][Full Text] [Related]
10. Novel poly(hydroxyalkanoates)-based composites containing Bioglass® and calcium sulfate for bone tissue engineering.
García-García JM; Garrido L; Quijada-Garrido I; Kaschta J; Schubert DW; Boccaccini AR
Biomed Mater; 2012 Oct; 7(5):054105. PubMed ID: 22972204
[TBL] [Abstract][Full Text] [Related]
11. Bioactive hydroxyapatite coatings on polymer composites for orthopedic implants.
Auclair-Daigle C; Bureau MN; Legoux JG; Yahia L
J Biomed Mater Res A; 2005 Jun; 73(4):398-408. PubMed ID: 15892136
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of bioactive calcium silicate and poly(epsilon-caprolactone) nanocomposite for bone tissue regeneration.
Wei J; Heo SJ; Liu C; Kim DH; Kim SE; Hyun YT; Shin JW; Shin JW
J Biomed Mater Res A; 2009 Sep; 90(3):702-12. PubMed ID: 18563819
[TBL] [Abstract][Full Text] [Related]
13. Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bioactive glass contents. Part I: Initial mechanical properties and bioactivity.
Niemelä T; Niiranen H; Kellomäki M; Törmälä P
Acta Biomater; 2005 Mar; 1(2):235-42. PubMed ID: 16701800
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
Wei J; Chen F; Shin JW; Hong H; Dai C; Su J; Liu C
Biomaterials; 2009 Feb; 30(6):1080-8. PubMed ID: 19019424
[TBL] [Abstract][Full Text] [Related]
15. Effect of glass composition on the degradation properties and ion release characteristics of phosphate glass--polycaprolactone composites.
Prabhakar RL; Brocchini S; Knowles JC
Biomaterials; 2005 May; 26(15):2209-18. PubMed ID: 15585222
[TBL] [Abstract][Full Text] [Related]
16. Effects of heat treatment on the bioactivity of surface-modified titanium in calcium solution.
Sultana R; Hamada K; Ichikawa T; Asaoka K
Biomed Mater Eng; 2009; 19(2-3):193-204. PubMed ID: 19581714
[TBL] [Abstract][Full Text] [Related]
17. The influence of hydroxyapatite particles on in vitro degradation behavior of poly epsilon-caprolactone-based composite scaffolds.
Guarino V; Taddei P; Di Foggia M; Fagnano C; Ciapetti G; Ambrosio L
Tissue Eng Part A; 2009 Nov; 15(11):3655-68. PubMed ID: 19496680
[TBL] [Abstract][Full Text] [Related]
18. In situ pH within particle beds of bioactive glasses.
Zhang D; Hupa M; Hupa L
Acta Biomater; 2008 Sep; 4(5):1498-505. PubMed ID: 18502193
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of bioactivity in sol-gel-derived glasses by X-ray spectroscopy.
Skipper LJ; Sowrey FE; Pickup DM; Fitzgerald V; Rashid R; Drake KO; Lin Z; Saravanapavan P; Hench LL; Smith ME; Newport RJ
J Biomed Mater Res A; 2004 Aug; 70(2):354-60. PubMed ID: 15227682
[TBL] [Abstract][Full Text] [Related]
20. Weight loss, ion release and initial mechanical properties of a binary calcium phosphate glass fibre/PCL composite.
Ahmed I; Parsons AJ; Palmer G; Knowles JC; Walker GS; Rudd CD
Acta Biomater; 2008 Sep; 4(5):1307-14. PubMed ID: 18448401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
